The pulmonary diffusing capacity for oxygen (DLo,) is of great physiological and clinical significance (1). Its measurement, however, is relatively complex (2). Pulmonary diffusing capacity for carbon monoxide (DLco) which, it is usually assumed,' can be converted to DL02 from the known solubilities and molecular weights of the two gases, is, in general, more readily measured. Further, since the rate of reaction of carbon monoxide with hemoglobin has been measured (4) in vitro while that of oxygen has not, determination of DLco at two or more alveolar oxygen tensions makes possible the computation of pulmonary capillary blood volume and pulmonary membrane diffusing capacity (5-7).
per cent CO and 10 per cent He in air (or in oxygen)2 equal to the subject's one second vital capacity is attached to the three-way tap, the clamps on the bag are removed and the bag and analyzer circuit mixed by the pump.3 A bag-in-box device attached to a spirometer has been found convenient for filling the bag. The subject then expires fully through the open arm of the three-way tap, following which the tap is turned to connect him with the bag. The subject rebreathes into the bag for 30 to 45 seconds at a rate of 30 cycles per minute in time to a metronome, endeavoring to empty the bag on each inspiration. At the end of this period the tap is closed, the pump is stopped and the bag clamped and removed. Before and after the measurement of diffusing capacity the equilibrium pCO of the subject's blood is determined by a rebreathing technique (13) . The bag is then analyzed for oxygen, carbon dioxide and helium by passing its contents successively through a paramagnetic oxygen analyzer,4 an infrared CO2 analyzer5 and a katharometer. 6 Carbon dioxide is adsorbed before the sample is passed through the katharometer.
B. Calculations. The volume of the lung-bag system is calculated from the equation:
FbVb
Fr,
where V\ = volume of the lung-bag system in milliliters STPD, Vb = volume of rebreathing bag in milliliters STPD, Fb = concentration of helium in the bag at start of rebreathing and F, = concentration of helium in bag at end of rebreathing. Vb is obtained from the record of the spirometer attached to the bag-in-box from which the bag is filled. Fb and FR are determined by katharometer analysis of the gas mixture used and of the bag contents at the end of rebreathing. Since C02 is absorbed before the gas is passed through the katharometer, this last reading is multiplied by 1 This record is measured at any desired interval, usually five seconids. From this measured deflection is suLbtracted the deflectioni produced by passing 5 per cent CO2 through the CO anialyzer. In two subjects the error introduced by the use of a standard correction for CO2 was investigated by placinig an infrared CO2 analyzer in the circuit and recordinig simultaneously CO and CO2 conicenitration in the bag. Each point of the CO record couild then be corrected for the deflection duie to the CO2 present at that poinlt by uisinig a calibration cturve for the sensitivity of the CO analyzer to CO2. The After the miieasLured poinits are corrected for C02, the CO concenitrationis are read from a calibrationi curve and these values are corrected for the back pressure of CO in the pulmonary capillaries. The back pressure is calculated by interpolating between the initial and final equiilibriulm CO values obtained as described above and multiplying this interpolated v-alue by the fraction PO2 (bag)/pO2 (equilibrium sample). This correctioni is only approximate since it assumes that all hemoglobini (Hb) is in the form 02Hb.
After this finial correctioni, the values for CO conicentrationi are plotted against time oni semilogarithmic paper. A line is drawni through the poinits beginninig with the final concentrationi. From Table IV. fall of CO was exponential after 21 to 25 seconds of rebreathinig. When this apparently exponential decrease did not begin with the first measured point, the plot of log CO concentration prior to this time showed a gradually decreasing slope similar to that illustrated in Figure 2 . This is probably due to concurrent mixing of the bag aind the alveoli and diffusion from the alveoli into the blood. Those subjects in whom 10 seconds or more of rebreathing elapsed before CO conicentration began to fall in an exponential mannier usually had emphysema.
The continuous sampling method used in these studies was compared with discrete sampling at three points in five studies in four normal subjects (Table I) . For The final CO conicentration in each bag was measured, plotted againist time and DLco calculated from the line connecting these poinlts. As shown in Table I , this method of sampling did not give results significantly different from con- niormal subjects anid in four patienits with emphysema ( Figure 5 ). Variance analysis of the data for normal subjects showed nio signiificant difference among the rates studied. Three of the four patients showed a lower value for DIco at the higher rate.
The effect of decreasinig bag volume below the vital capacity was studied in four normal subjects ( Figure 6 ). There is a marked decrease in calculated DLco wheni the bag volume was about 25 per cent of the vital capacity, i.e., wheni the total volume of the lung-bag system approximated the subject's functioinal residual capacity.
Our data onl the rebreathing DLco in 47 subjects free from heart, lung or hematologic disease are shown in Table II Hg in four normal subjects and five patients without airway obstruction. The regression line is for the data onl normal subjects and patients without airway obstructioni. As discussed below, different theoretical considerations apply to the measurement of DLco by rebreathing in emphysematous patients. Figure 8 shows a similar comparison of the steady state aind rebreathing measurements of DLCO for five normal subjects, four patients without airway obstruction and three patients with emphysema. No relationi between the two measurements is evident from the rather few data available. In Figure 9 the residual volume calculated from rebreathiiig data as explained above is compared with the residual volume determined in duplicate by the closed circuit helium method (14) in 28 where FI = concentration of CO in inspired gas, The second and third assumptions made above, however, are certainly incorrect. Further, we have continuously analyzed the helium concentration of the rebreathing circuit and found that slow mixing continues throughout a 45 second period in emphysematous patients (18) .
Thus the use of Krogh's equation (8) to calculate DLco in a rebreathing system which is ventilated breath by breath at a finite rate may lead to errors in the value obtained. To evaluate the magnitude of these errors we have approached the problem empirically, using a mathematical model of the lung consisting of two regions ( Figure 2 ). DL/VA and DL/VA are uniform within the region and may or may not be uniform between the regions (Table IV) . With some labor, the concentration of an insoluble gas (helium) and a diffusible gas (CO) may be calculated at the end of each of the 23 (17) .
The total alveolar volume during breath-holding is 6,500 ml. and the duration of breath-holding is 10 seconds. The effective tidal volume during the steady state technique is one-third that during rebreathing and the rate is 10 cycles per minute. time thought that it was not, while Marshall (20) , after repeating the same experiment, concluded that DL/VA is uniform. In emphysematous patients Marshall (20) found that CO concentration varied during a single expiration and concluded that DL/VA is non-uniform. Surprisingly, he also found that the ratio of an insoluble gas (helium) to CO during an expiration was uniform, indicating the same ratio of DL/VA throughout the lung. Ogilvie, Forster, Blakemore and Morton (9) also found that the ratio of He to CO was the same in an "early" as in a "late" expiratory sample in patients with emphysema.
If DL/VA is uniform in the lungs of normal subjects, there should be a high correlation between the rebreathing and single breath methods in these subjects. Such a correlation is found in our data ( Figure 7) . Further, the points for patients with emphysema scatter about the same regression line, supporting Marshall's (20) conclusion that DL/VA is uniform in these patients. From the available evidence, therefore, the theoretical advantage that the rebreathing DLco is independent of non-uniform DL/VA (infinite rate) or relatively insensitive non-uniform DL/VA (finite rate) does not make the rebreathing DLco more valid than the single breath DLco.
If the same type of reasoning is applied to the relation between the steady state DLco and the rebreathing DLco, one would predict a high correlation between the two methods for normal subjects and a poor correlation for emphysematous patients. These predictions are not supported by our data (Figure 8 ). However, no conclusions seem warranted because 1) the data are relatively few, 2) the lung volumes during the measurements of rebreathing and steady state DLco differ. Marshall (20) has pointed out that steady state DLco increases with lung volume and we have found a similar relation of rebreathing DLco to lung volume ( Figure 6 ). 3) The steady state measurements were performed at rest and the potential errors of the steady state method are greatest at rest (10) .
Practical advantages of rebreathing
The following practical advantages are unique to the rebreathing method:
1) The method incorporates a continuous internal check on CO analysis. The required measurements of CO are made within seconds of each other, while the rebreathing is going on. Further, the concentration of CO should fall exponentially during a valid study. Thus, any error due to malfunction of the analyzer or leak in the system is readily detected.
2) A measurement of residual volume is obtained simultaneously with a measurement of DLco. There is a satisfactory correlation between the residual volume so obtained and a measurement using a seven minute, closed circuit, helium technique (14) (Figure 9) . A corollary advantage of the rebreathing method is that calculation of the total volume of the lung-bag system by helium dilution guards against errors which may occur in the single breath method through failure of the subject to expire to his residual volume at the start of the procedure.
3) A complete measurement of DLco is very rapid. CO analysis is completed during rebreathing. The record of the CO analyzer may be measured at a minimum of three points while the rebreathing bag is analyzed for helium and carbon dioxide. All measurements and calculations can be completed in 10 minutes or less.
The following advantages of the rebreathing method are shared by either the steady state or the single breath methods:
1) No blood samples are required. 2) Rebreathing is readily carried out by patients and untrained subjects.
3) The method can be used in subjects with a low vital capacity. 4) Required analysis can be done by physical methods and without highly skilled personnel.
Disadvantages of the rebreathing method
The rebreathing method has the following disadvantages: 1) Rebreathing involves considerable exercise of the respiratory muscles. We have measured the oxygen consumption'0 during rebreathing in six normal subjects by sampling continuously the oxygen concentration in the lung-bag system with a mass spectrometer."1 The difference in 10 The rebreathing DLCO is well correlated with the single breath DLCO (Figure 7) and, like the single breath DLCO, increases with body surface area, height and weight (9) . Application of our regression equations and those of Ogilvie and associates (9) Figure 7 values for the single breath DLco are, in general, higher than for the rebreathing DLco in the same individual. These differences, however, do not reach the level of statistical significance.
The DLCO for normal females in our series is less than that for normal males. This is usually attributed to the smaller body size of women (1) . Yet when our regression equations are applied to normal females, the predicted values are higher than those actually found. Thus, the average body surface area for our female subjects was (Figure 8 ).
Results in patients
Of our 19 patients with emphysema (Table  III) , in only five (N. F., E. N., J. C., G. V., W. F.) was the rebreathing DLco decreased a third or more below the predicted value based oIn body surface area (or weight). Thus, in 14 of these patients there was no marked impairment of diffusion. Kjerulf-Jensen and Kruh0ffer (26) , using a C140 rebreathing method, report similar findings. Only four of their 12 emphysematous patients had a DLCo a third or more below the predicted value. In 10 of our emphysematous patients, DLco was also measured by the single breath technique. Only three of these (S. P., G. V. and W. F.) had a value for DLco less than two-thirds of the predicted value. Marshall (20) , also using the single breath technique, found that the DLco was decreased by a third or more in only three of 11 emphysematous patients.
These findings must be contrasted with those of Ogilvie and associates (9) , using the single breath technique; Bates, Knott and Christie (24) , using the alveolar sample steady state technique and Donald, Renzetti, Riley and Cournand (27) , using the steady state oxygen method. All of these investigators concluded that diffusion was usually impaired in emphysema.
When the same method gives conflicting results [cf. the results of Marshall (20) and of Ogilvie and associates (9) ], the explanation presumably lies in the selection of patients. As far as the differences among the methods are concerned, we have set forth above our reasons for believing that the rebreathing DLco gives reasonably valid results in emphysematous patients despite the fact that ventilation is grossly uneven in this disease. Marshall (20) has presented evidence that the alveolar sample steady state DLco gives erroneously low values in emphysema and Kjerulf-Jensen and Kruh0ffer (26) have criticized the use of the Bohr integration for determining mean capillary PO2 in the steady state oxygen method (2) . DLco in our four patients with sarcoid varied from markedly impaired (D. B. and M. B.) to normal (J. S.). Impairment of diffusion in sarcoid was first demonstrated by Austrian and co-workers (28) . Williams (29) has emphasized the frequent occurrence of normal pulmonary function in sarcoid despite widespread pulmonary involvement by X-ray.
Other authors using different techniques have reported results similar to ours in interstitial fibrosis (28) , radiation fibrosis (30), anemia (31) , polycythemia (31) and the "Pickwickian" syndrome (32) . SUMMARY 1. This paper describes a rebreathing method for the measurement of pulmonary diffusing capacity for carbon monoxide (DLco) using stable CO and continuous analysis.
2. The fall of CO concentration in the rebreathing bag was apparently exponential for at least 15 seconds in 571 of 578 studies. In 80.4 per cent of these studies, this exponential decrease began in the first 10 seconds of rebreathing.
3. In four normal subjects calculated DLco was independent of increases in apparatus dead space. This would be true if the rate of rebreathing were infinitely fast.
4. In patients with emphysema calculated DLCo decreases as apparatus dead space is increased. This would occur if the rebreathing system were ventilated breath by breath at a finite rate.
5. In four normal subjects the rebreathing DLco decreased sharply when the total volume of the lung-bag system was decreased from near total lung capacity to approximately functional residual capacity. 6 . In 47 normal subjects the rebreathing DLco was significantly correlated with height, weight, body surface area and vital capacity.
7. There is a high correlation between rebreathing and single breath measurements of DLco in normal subjects and patients without airway obstruction. There is a less striking correlation between these two methods in patients with emphysema. 8 . The residual volume determined by the rebreathing method is significantly correlated with that measured by the closed circuit helium method in both normal subjects and patients.
9. An empiric argument is presented for the approximate validity of the rebreathing method in patients with uneven ventilation and slow mixing in whom the rate of rebreathing is finite. 10 . The rebreathing method is rapid, simple and gives a simultaneous measurement of DLco and residual volume.
11. The rebreathing DLco was definitely decreased (two-thirds or less the predicted value) in only five of 19 patients with emphysema.
APPENDIX I
The diagnosis of emphysema in patients H. K. through J. C. (Table III ) was based on: 1) a low one second vital capacity and/or maximum breathing capacity, 2) an increased residual volume and 3) slight or no improvement in these tests after bronchodilators. All patients were dyspneic and their physical findings and X-rays were compatible with chronic obstructive emphysema. Of these patients, complicating diseases were present in the following: S. P. was compatible with sarcoid histologically. D. B. and M. B. were dyspneic while W. S. and J. S. were working full time. W. Se. had relentlessly progressive dyspnea for two years. Chest X-ray revealed diffuse fibrotic infiltration. E. J. received Co6O therapy after radical removal of carcinoma of the left breast. At the time of these studies she had a severe cough and a soft tissue density was present in the apical and infraclavicular portions of the left lung field. A. P. had widespread miliary calcific densities on chest X-ray. He was severely dyspneic. Histoplasmin and tuberculin skin tests were positive, but cultures for tuberculosis were negative. R. J. was diabetic and had a hemolytic anemia of unknown cause. His hemoglobin at the time of study was 8.0 Gm. per cent. WV. Sh. was anemic because of bleeding from a small bowel tumor. Her hemoglobin was 6.9 Gm. per cent. The hemoglobin in S. S. was 18.6 Gm. per cent. G. G. had exudative lesions in both upper lung fields. Sputum smear was positive for tuberculosis. L. D. was somnolent, dyspneic, weak and grossly obese. H. B. had a markedly increased anteroposterior diameter of the chest with dorsal kyphosis. The lung fields showed increased radiolucency. F. H. was hypertensive (190/90 mm. Hg) and had been in congestive heart failure twice before. He had a lesion of the left mid-lung field that proved to be carcinoma at thoracotomy. J. Sh. had the classic murmur of mitral stenosis. She had several episodes of acute pulmonary edema. During full expiration, which also lasts t minutes, the concentration of CO remaining in the ith alveolus falls by the Di Pb t power e (vA-VT). On the second breath the concentration of CO in the dead space is F8.. The ith alveolus receives first a volume (VDi) of the mixed alveolar gas in the dead space at the end of expiration (the "alveolar" part of the equation for F81) and then a volume (VT -VD) i of the gas in the bag. Both of these moieties are mixed with the gas remaining in the alveoli during expiration to give the concentration of CO at the end of the second inspiration. During a full inspiration of t minutes, CO again diffuses out of the alveolus as explained above. The concentration of CO in the bag at the end of the second expiration (F,,) is: VD + VD. VT -V
